Aarey Drugs & Pharmaceuticals LimitedAAREYDRUGSNSE
Aarey Drugs allots 11.5 lakh shares on warrant conversion
As filed · Aarey Drugs & Pharmaceuticals Limited has informed the Exchange regarding Outcome of Board Meeting held on August 06, 2026.
CapitalMixedMinormateriality 48 out of 100
What happened
FactAarey Drugs and Pharmaceuticals approved the allotment of 11,50,000 equity shares following conversion of fully convertible warrants. The company received Rs. 47.85 per warrant, aggregating to Rs. 5,50,27,500, and its paid-up share capital increased to 3,18,74,303 shares from 3,07,24,303 shares.
Why it matters
CapitSignal interpretationShares are issued to named investors at a set price, diluting existing holders and changing who sits on the register.
Watch next
Fact- Who the allottees are
- Issue price versus market price
- Lock-in period on the new shares
Evidence
How CapitSignal classified this
- Reasoning:
- The conversion increases the company’s equity base by 11,50,000 shares and brings in Rs. 5,50,27,500. A further 14,80,000 warrants remain outstanding for potential conversion, which could result in additional equity issuance.
- Matched on:
- the filing's own subject line
- Confidence in the event type:
- 90%